Open AccessDual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents
Author(s) -
Giuseppe Ferrante,
Gianluigi Condorelli,
Paolo Pagnotta,
Bernhard Reimers
Publication year - 2017
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.116.004139
Subject(s) - medicine , odds ratio , myocardial infarction , confidence interval , cardiology , drug eluting stent , randomized controlled trial , percutaneous coronary intervention , stent , surgery
The benefits and harms of dual antiplatelet therapy (DAPT) continuation beyond 1 year after drug-eluting stent implantation as compared with 1-year DAPT remain controversial.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom